[Federal Register Volume 77, Number 177 (Wednesday, September 12, 2012)]
[Notices]
[Pages 56215-56216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-22384]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Target Discovery and Development Network.
Date: October 18-19, 2012.
Time: 6 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Suite 703, Room 7072 Bethesda, MD 20892-8329, 301-594-1408,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Validation and Advanced Development of Emerging Technologies
for Cancer Research.
Date: October 30, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
[[Page 56216]]
Place: National Institutes of Health, 6120 Executive Boulevard,
Room 511, Rockville, MD 20852.
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review & Logistics Branch, Division of Extramural
Activities, 6116 Executive Boulevard, Room 8146, National Cancer
Institute, NIH, Bethesda, MD 20892-8329, 301-594-1566,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Quantitative Imaging for Evaluation of Responses to Cancer
Therapies.
Date: October 31, 2012.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 611, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8101 Bethesda, MD 20892-8329 301/496-7987
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Diagnostic and Therapeutic Agents Enabled by
Nanotechnology.
Date: November 27, 2012.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6120 Executive Boulevard,
Room J, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Savvas C. Makrides, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard., Room 8050A Bethesda, MD 20892, 301-496-7421
[email protected].
Information is also available on the Institute's/Center's home
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 6, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-22384 Filed 9-11-12; 8:45 am]
BILLING CODE 4140-01-P